| Literature DB >> 33929935 |
Samuel Cordey1,2, Florian Laubscher1,2, Mary-Anne Hartley3,4, Thomas Junier5,6, Kristina Keitel7,8, Mylène Docquier9,10, Nicolas Guex11, Christian Iseli11, Gael Vieille1,2, Philippe Le Mercier12, Anne Gleizes12, Josephine Samaka13, Tarsis Mlaganile13, Frank Kagoro13, John Masimba13, Zamzam Said13, Hosiana Temba13, Gasser H Elbanna4, Caroline Tapparel14, Marie-Celine Zanella1,2, Ioannis Xenarios15,16, Jacques Fellay5,6,17, Valérie D'Acremont3,7, Laurent Kaiser1,2,18.
Abstract
Viral infections are the leading cause of childhood acute febrile illnesses motivating consultation in sub-Saharan Africa. The majority of causal viruses are never identified in low-resource clinical settings as such testing is either not part of routine screening or available diagnostic tools have limited ability to detect new/unexpected viral variants. An in-depth exploration of the blood virome is therefore necessary to clarify the potential viral origin of fever in children. Metagenomic next-generation sequencing is a powerful tool for such broad investigations, allowing the detection of RNA and DNA viral genomes. Here, we describe the blood virome of 816 febrile children (<5 years) presenting at outpatient departments in Dar es Salaam over one-year. We show that half of the patients (394/816) had at least one detected virus recognized as causes of human infection/disease (13.8% enteroviruses (enterovirus A, B, C, and rhinovirus A and C), 12% rotaviruses, 11% human herpesvirus type 6). Additionally, we report the detection of a large number of viruses (related to arthropod, vertebrate or mammalian viral species) not yet known to cause human infection/disease, highlighting those who should be on the radar, deserve specific attention in the febrile paediatric population and, more broadly, for surveillance of emerging pathogens.Trial registration: ClinicalTrials.gov identifier: NCT02225769.Entities:
Keywords: Blood virome; children; fever; metagenomic next-generation sequencing; virosphere
Year: 2021 PMID: 33929935 DOI: 10.1080/22221751.2021.1925161
Source DB: PubMed Journal: Emerg Microbes Infect ISSN: 2222-1751 Impact factor: 7.163